Highlighting its expanding role in advanced healthcare and clinical research, King Faisal Specialist Hospital and Research Centre (KFSH) was responsible for conducting 48% of all clinical trials registered in Saudi Arabia during the first half of 2025. This significant contribution underscores the hospital’s dedication to pioneering clinical studies and improving healthcare outcomes. The hospital’s research activities are bolstered by a comprehensive team comprising investigators, research nurses, pharmacists, coordinators, data specialists, and regulatory and ethics teams. These professionals collectively ensure the seamless progression of clinical studies from the initial scientific planning stages through to patient recruitment, trial execution, safety oversight, and data management.
Established in 2020, KFSH’s centralized Clinical Trials service plays a crucial role in coordinating research efforts by clinicians and investigators. This service facilitates important aspects of clinical trials, including feasibility evaluations, study initiation, trial operations, patient recruitment, the management of investigational medicines, data quality assurance, safety reporting, and adherence to regulatory and ethical standards. In the first half of 2025 alone, KFSH was actively involved in 104 clinical trials, with an additional 80 new studies initiated. These research endeavors span a diverse array of medical fields such as cancer, cardiovascular ailments, autoimmune and musculoskeletal conditions, dermatology, gastroenterology, liver disease, and endocrine and metabolic disorders, thereby offering patients with complex health issues access to innovative treatment options while simultaneously contributing valuable clinical evidence pertinent to Saudi Arabia’s healthcare landscape.
Among the hospital’s noteworthy advancements is the initiation of a Phase I clinical trial for treating relapsed acute lymphoblastic leukemia using genetically engineered CAR-T cells manufactured within the country. This trial exemplifies the integration of local scientific expertise, cutting-edge biomanufacturing capabilities, and specialized clinical care within a singular research framework, marking a significant milestone in advancing cell therapy research.
Beyond its national impact, KFSH’s centralized clinical-trial infrastructure also enhances its capability to engage in sophisticated international research collaborations. The hospital’s robust research governance and specialized clinical expertise lay the groundwork for meaningful partnerships with multinational research entities, ensuring that patient safety, ethical standards, data quality, and regulatory compliance are maintained. KFSH is scheduled to present its pioneering approach to clinical research and healthcare innovation at the C3 US NYC Davos of Healthcare Summit 2026 in New York City on September 14.
KFSH’s reputation as a leading academic medical center is recognized both globally and within the Middle East, with the hospital frequently appearing in international hospital rankings and receiving accolades for its healthcare brand. Situated in Riyadh, Saudi Arabia, KFSH continues to set benchmarks in healthcare and clinical research, reinforcing its position at the forefront of medical innovation.
Legal Disclaimer:
The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.